dihexa peptide cognition (PNB-0408) | c-Met/HGFR Activator Dihexa Peptide Therapy: Brain &

However, the inflammatory response surrounding the herniation, the condition of the annulus fibrosus, and the health of supporting musculature all represent potential targets

All independently tested

benzene ring(s) ) replacing O with S addition of a halogen ( F, Cl, Br, I ) Factors decreasing lipid solubility ( drug reabsorption in kidney tubules) - additions commonly produced by metabolism to enhance excretion - these groups increase hydrogen bonding with water ( hydrophilicity) Addition of: - COOH - OH - NH 2 - O-CH 3 - SO 4 2- - glucuronic acid Examples of Drugs with Significant First Pass Effect or Low Bioavailability Drug: Propranolol- ~26% Bioavailability because 75-85 % is metabolized by the liver before it can reach the circulation when taken orally

Two separate human clinical trials (ulcerative colitis and multiple sclerosis) proceeded without significant adverse event reporting

Nevertheless, these results are preliminary and cannot be considered proof of clinical efficacy in humans